In Brief: Cenci
Executive Summary
Cenci: FDA bars former Cenci Director of Regulatory Affairs Nancy Banks "from providing services in any capacity to a person that has an approved or pending drug product application," an Aug. 28 Federal Register notice states. A Maryland federal court entered a judgment against Banks on Jan. 25 for the count of making fraudulent statements in an annual report regarding stability tests for Cenci's promethazine syrup products...